1224 infection control & hospital epidemiology october 2017, vol. 38, no. 10 acknowledgments
Financial support: This study was supported by a grant from the Department of Health, Taiwan (grant no. DOH98-DC-1005). The funding organization was not involved in the design or conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript. Potential conflicts of interest: All authors report no conflicts of interest rele-
vant to this article. Address correspondence to Shey-Ying Chen, MD, Department of
Emergency Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University. No. 7, Zhongshan S Rd, Zhongzheng District, Taipei City 100, Taiwan (
erdrcsy@ntu.edu.tw).
supplementary material
To view supplementary material for this article, please visit
https://doi.org/10.1017/ice.2017.178
references 1. Pop-Vicas AE, D’Agata EMC. The rising influx of multidrug- resistant gram-negative bacilli into a tertiary care hospital. Clin Infect Dis 2005;40:1792–1798.
2. Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st cen- tury—a clinical
super-challenge.NEngl J Med 2009;360:439–443.
3. Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum beta-lacta- mases (ESBLs) in the community. J Antimicrob Chemother 2005;56:52–59.
4. Ben-Ami R, Rodríguez-Baño J, Arslan H, et al. A multinational survey of risk factors for infection with extended-spectrum beta- lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 2009;49:682–690.
5. Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 2006;42(Suppl 2):S82–S89.
6. Evans HL, Lefrak SN, Lyman J, et al. Cost of gram-negative resistance. Crit Care Med 2007;35:89–95.
7. Roberts RR, Hota B, Ahmad I, et al. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis 2009;49:1175–1184.
8. Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta- analysis. J Antimicrob Chemother 2007;60:913–920.
9. Vallés J, Rello J, Ochagavía A, Garnacho J, Alcalá MA. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest 2003;123:1615–1624.
10. Mammina C, Di Carlo P, Cipolla D, et al. Surveillance of multidrug-resistant gram-negative bacilli in a neonatal intensive care unit: prominent role of cross transmission. Am J Infect Control 2007;35:222–230.
11. Giuffrè M, Geraci DM, Bonura C, et al. The increasing challenge of multidrug-resistant gram-negative bacilli: results of a 5-year active surveillance program in a neonatal intensive care unit. Medicine (Baltimore) 2016;95:e3016.
12. Reddy P, Malczynski M, Obias A, et al. Screening for extended- spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia. Clin Infect Dis 2007;45:846–852.
13. Otter JA, Mutters NT, Tacconelli E, Gikas A, Holmes AH, et al. Controversies in guidelines for the control of multidrug-resistant gram-negative bacteria in EU countries. Clin Microbiol Infect 2015;21:1057–1066.
14. Tumbarello M, Trecarichi EM, Bassetti M, et al. Identifying patients harboring extended-spectrum-beta-lactamase-produ- cing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. Antimicrob Agents Chemother 2011;55:3485–3490.
15. Johnson SW, Anderson DJ, May DB, Drew RH. Utility of a clinical risk factor scoring model in predicting infection with extended-spectrum β-lactamase-producing enterobacteriaceae on hospital admission. Infect Control Hosp Epidemiol 2013;34:385–392.
16. Augustine MR, Testerman TL, Justo JA, et al. Clinical risk score for prediction of extended-spectrum β-lactamase-producing Enterobacteriaceae in bloodstream Isolates. Infect Control Hosp Epidemiol 2017;38:266–272.
17. Kengkla K, Charoensuk N, Chaichana M, et al. Clinical risk scoring system for predicting extended-spectrum β-lactamase- producing Escherichia coli infection in hospitalized patients. J Hosp Infect 2016;93:49–56.
18. Tacconelli E, Cataldo MA, De Pascale G, et al. Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. J Antimicrob Chemother 2008;62: 1130–1137.
19. Ruppé E, Pitsch A, Tubach F, et al. Clinical predictive values of extended-spectrum beta-lactamase carriage in patients admitted to medical wards. Eur J Clin Microbiol Infect Dis 2012;31:319–325.
20. Platteel TN, Leverstein-van Hall MA, Cohen Stuart JW, et al. Predicting carriage with extended-spectrum beta-lactamase- producing bacteria at hospital admission: a cross-sectional study. Clin Microbiol Infect 2015;21:141–146.
21. Vasudevan A, Mukhopadhyay A, Li J, Yuen EG, Tambyah PA. A prediction tool for nosocomial multi-drug resistant gram- negative bacilli infections in critically ill patients—prospective observational study. BMC Infect Dis 2014;14:615.
22. Snyder GM, D’Agata EM. Diagnostic accuracy of surveillance cultures to detect gastrointestinal colonization with multidrug- resistant gram-negative bacteria. Am J Infect Control 2012; 40:474–476.
23. Siegel JD, Rhinehart E, Jackson M, Chiarello L. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 2007;35(Suppl 2):165–193.
24. McNeil BJ, Hanley JA. Statistical approaches to the analysis of receiver operating characteristic (ROC) curves. Med Decis Making 1984;4:137–150.
25. Laupacis A, Sekar N, Stiell IG. Clinical prediction rules. A review and suggested modifications of methodological standards. JAMA 1997;277:488–494.
26. Diagnosis. In Fletcher RH, Fletcher SW, Wagner EG, eds. Clinical Epidemiology: the Essentials. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 1996:48–50.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144
